As shown in Fig. 2A, we confirmed seven survival-related DE-LMRGs in GC patients, including ATP1B4, CD36, GGT5, GPX3, NNMT, CDO1 and CYP26C1. This evidence concerns the gene GPX3 and gastric cancer.